Hey there! Welcome!
Get updated on
Key Trials
Tuberculosis_1
Faropenem Achieves Noninferior Efficacy in Drug-Susceptible Pulmonary Tuberculosis
This study evaluated the noninferiority of replacing ethambutol with faropenem in 1st line treatment of drug-susceptible pulmonary TB. Faropenem achieved comparable treatment & microbiological outcomes with a more favorable safety profile & fewer AEs.

Spotlight

PodCast
Conference Highlights
Patient education
Guidelines
Slide Library
Pulmonary Hypertension
Pulmonologists’ Perspectives and Practice Patterns in India on the Diagnosis and Treatment of PH
This presentation summarizes the key findings based on pulmonologists’ perspectives from a survey conducted to understand clinicians perspectives and practice patterns in both the diagnosis and treatment of group 1 and group 3 PH, which can further help optimize the management of PH patients.
Resources

Resources

A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.

View all
Research

Our Research

Snapshots of clinical research on molecules and diseases conducted by Cipla.

View all